Literature DB >> 16525827

Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract.

C Langner1, G Hutterer, T Chromecki, P Rehak, R Zigeuner.   

Abstract

The biological significance of squamous and glandular differentiation and different patterns of invasion in upper urinary tract urothelial carcinoma is unclear. We reviewed 268 cases of consecutive upper urinary tract carcinomas with respect to the presence of squamous and/or glandular differentiation and different patterns of invasion (nodular, trabecular, and infiltrative) and correlated data with patient outcome. Squamous or glandular differentiation occurred in 47/268 (18%) tumors and its presence correlated with high tumor stage (P<0.001) and grade (P<0.001). Invasive patterns were nodular in 49/227 (22%), trabecular in 95/227 (42%), and infiltrative in 83/227 (37%) tumors. The nodular pattern prevailed in low stage (P<0.001) and low-grade (P<0.001) tumors, whereas the infiltrative pattern prevailed in high stage (P<0.001) and high-grade (P<0.001) tumors. Multivariate analysis proved that tumor stage (P<0.001) and the infiltrative pattern (P<0.001) are independent predictors of metastasis-free survival, whereas tumor grade and squamous and glandular differentiation lacked independent influence on patient outcome. In conclusion, the infiltrative pattern of invasion significantly correlated with advanced disease and poor patient outcome. In contrast, the presence of squamous and/or glandular invasion did not prove independent influence on patient outcome. The pattern of invasion should be commented upon separately in the pathology report.

Entities:  

Mesh:

Year:  2006        PMID: 16525827     DOI: 10.1007/s00428-006-0150-4

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  43 in total

1.  Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder.

Authors:  Marco G Bol; Jan P Baak; Susanne Buhr-Wildhagen; Arnold-Jan Kruse; Kjell H Kjellevold; Emiel A Janssen; Oddvar Mestad; Per Øgreid
Journal:  J Urol       Date:  2003-04       Impact factor: 7.450

2.  Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors: the M.D. Anderson experience.

Authors:  C J Logothetis; F H Dexeus; C Chong; A Sella; A G Ayala; J Y Ro; S Pilat
Journal:  J Urol       Date:  1989-01       Impact factor: 7.450

3.  Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma.

Authors:  L Cheng; R M Neumann; A Nehra; B E Spotts; A L Weaver; D G Bostwick
Journal:  Cancer       Date:  2000-04-01       Impact factor: 6.860

4.  Prognostic factors of primary transitional cell carcinoma of the upper urinary tract.

Authors:  S H Lee; J S Lin; T S Tzai; N H Chow; Y C Tong; W H Yang; C C Chang; H L Cheng
Journal:  Eur Urol       Date:  1996       Impact factor: 20.096

5.  Types of metaplasia in forty urothelial bladder carcinomas. A systematic histological investigation.

Authors:  H Starklint; J KJAERGAARD; N K Jensen
Journal:  Acta Pathol Microbiol Scand A       Date:  1976-03

6.  Prediction of response to radiotherapy in invasive bladder cancer.

Authors:  B J Jenkins; J E Martin; S I Baithun; R J Zuk; R T Oliver; J P Blandy
Journal:  Br J Urol       Date:  1990-04

Review 7.  Urothelial neoplasms of the kidney and ureter. An epidemiologic, pathologic, and clinical review.

Authors:  Elizabeth M Genega; Christopher R Porter
Journal:  Am J Clin Pathol       Date:  2002-06       Impact factor: 2.493

8.  Significance of T stadium and grading as prognostic factors in transitional cell carcinoma of the ureter.

Authors:  Enrico Fiori; Giuseppe Cavallaro; Claudia Paparelli; Alessandro Decesare; Marco Bononi; Gaspare Galati; Giuseppe Tiziano; Antonino Cavallaro; Vincenzo Cangemi
Journal:  Anticancer Res       Date:  2004 May-Jun       Impact factor: 2.480

9.  Impact of the 1998 World Health Organization/International Society of Urological Pathology classification system for urothelial neoplasms of the kidney.

Authors:  Elizabeth M Genega; Malathy Kapali; Marta Torres-Quinones; William C Huang; Jill S Knauss; Li-Ping Wang; Puthiyaveettil N Raghunath; Christopher Kozlowski; Stanley Bruce Malkowicz; John E Tomaszewski
Journal:  Mod Pathol       Date:  2005-01       Impact factor: 7.842

10.  Tumors of the upper urinary tract: 10 years of experience.

Authors:  L Charbit; M C Gendreau; S Mee; J Cukier
Journal:  J Urol       Date:  1991-11       Impact factor: 7.450

View more
  15 in total

1.  [Urothelial carcinoma of the upper urinary tract: clinical and pathological criteria and their predictive implications after radical nephroureterectomy].

Authors:  Christian Seitz; Paul Schramek
Journal:  Wien Med Wochenschr       Date:  2011-08

Review 2.  [Upper tract urothelial carcinoma. An update on clinical and pathological prognostic factors].

Authors:  M Rink; M Adam; J Hansen; F K Chun; S A Ahyai; M Remzi; T Schlomm; O Engel; R Heuer; C Eichelberg; M Fisch; R Dahlem; S F Shariat
Journal:  Urologe A       Date:  2012-09       Impact factor: 0.639

3.  Urothelial carcinoma with abundant myxoid stroma: evidence for mucus production by cancer cells.

Authors:  Magdalena M Gilg; Birgitta Wimmer; Arthur Ott; Cord Langner
Journal:  Virchows Arch       Date:  2012-05-26       Impact factor: 4.064

4.  CD24 expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression.

Authors:  Alexandra Winkler; Richard Zigeuner; Peter Rehak; Georg Hutterer; Thomas Chromecki; Cord Langner
Journal:  Virchows Arch       Date:  2006-11-17       Impact factor: 4.064

Review 5.  Prognostic factors for upper urinary tract urothelial carcinoma.

Authors:  Thomas F Chromecki; Karim Bensalah; Mesut Remzi; Grégory Verhoest; Eugene K Cha; Douglas S Scherr; Giacomo Novara; Pierre I Karakiewicz; Shahrokh F Shariat
Journal:  Nat Rev Urol       Date:  2011-07-05       Impact factor: 14.432

6.  Prognostic implication of infiltrative growth pattern and establishment of novel risk stratification model for survival in patients with upper urinary tract urothelial carcinoma.

Authors:  Takeshi Hashimoto; Jun Nakashima; Rie Inoue; Tatsuo Gondo; Yoshio Ohno; Masaaki Tachibana
Journal:  Int J Clin Oncol       Date:  2013-04-03       Impact factor: 3.402

Review 7.  Predictive factors of recurrence and survival of upper tract urothelial carcinomas.

Authors:  Grégory Verhoest; Shahrokh F Shariat; Thomas F Chromecki; Jay D Raman; Vitaly Margulis; Giacomo Novara; Christian Seitz; Mesut Remzi; Morgan Rouprêt; Douglas S Scherr; Karim Bensalah
Journal:  World J Urol       Date:  2011-06-17       Impact factor: 4.226

8.  Comparison of clinicopathological features in metastatic upper tract urothelial carcinoma and urothelial bladder cancer.

Authors:  Jing Xie; Xue-Bin Zhang; Jin Wen; Yu-Shi Zhang; Han-Zhong Li
Journal:  Int Urol Nephrol       Date:  2016-01-21       Impact factor: 2.370

9.  Squamous differentiation and prognosis in upper urinary tract urothelial carcinoma.

Authors:  Naohiro Makise; Teppei Morikawa; Taketo Kawai; Tohru Nakagawa; Haruki Kume; Yukio Homma; Masashi Fukayama
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

10.  Impact of squamous differentiation on intravesical recurrence and prognosis of patients with upper tract urothelial carcinoma.

Authors:  Jianpeng Yu; Gang Li; Aixiang Wang; Qiang Luo; Zihao Liu; Yuanjie Niu; Yanhui Mei
Journal:  Ann Transl Med       Date:  2019-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.